|
AMDL, INC, (ADL) Stock Rating Learn More
| Our Overall Rating on AMDL, INC, ADL is Not Available | | AMDL, Inc. primarily engages in the commercial development of diagnostic tumor-marker test kits to detect the presence of multiple types of cancer. Its products are used by hospital, clinical, research, and forensic laboratories; and doctors offices to identify certain types of cancer and other diseases. The company develops, manufactures, markets, and offers for sale various immunodiagnostic kits for the detection of cancer and other diseases. Its DR-70 test kit is used in the detection of 13 types of cancer, including lung (small and nonsmall cell), stomach, breast, rectal, colon, and liver. As of December 31, 2003, DR-70 had not been cleared by the FDA. The companys other product, Pylori- Probe, an In Vitro Diagnostic test for antibodies to H. pylori bacterium, is cleared by FDA for sale in the United States. AMDL was founded in 1989 and is headquartered in Tustin, California. | | Our Not Available Rating on ADL was issued on 11/19/2008 |
AMDL, INC Technical Rating
|
